J. Christopher Barry has spent his career focused in the medical technology industry at Medtronic and currently CEO of NuVasive.
The Latest
From outgoing leaders to new board members, here are nine updates on executive leadership at spine and orthopedic device companies in the last 60 days.
Eight more operating rooms are being added to Hunterdon Medical Center in Flemington, N.J., including two ORs that will be used specifically for spine and total joint surgeries, Mycentraljersey.com reported Aug. 19.
The U.S. Court of Appeals for the Federal Circuit on Aug. 18 refused to revive claims in a NuVasive spine surgery patent case, siding with a previous decision made by the Patent Trial and Appeal Board.
The minimally invasive spinal implants market reached nearly $2 billion in 2020, and it's expected to hit close to $3 billion by 2027, according to iData Research.
Ortho Regenerative Technologies has extended its clinical hold on its Ortho-R drug, according to an Aug. 20 news release.
Alex Gorsky will step down as chair and CEO of Johnson & Johnson and serve as executive chairman effective Jan. 3, 2022.
Saqib Hasan, MD, of Oakland, Calif.-based Webster Orthopedics, is the first fellowship-trained full-endoscopic spine surgeon in the U.S.
Olympia (Wash.) Orthopaedic Associates will open a spine center, according to an Aug. 19 announcement in Thurston Talk.
Missouri's largest medical school, Kansas City University, is shifting its orthopedic residency program to Research Medical Center, one of HCA Midwest Health's family of hospitals in the region.